Chemed
464 hedge funds and large institutions have $7.77B invested in Chemed in 2023 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 183 increasing their positions, 155 reducing their positions, and 39 closing their positions.
215% more call options, than puts
Call options by funds: $3.9M | Put options by funds: $1.24M
18% more repeat investments, than reductions
Existing positions increased: 183 | Existing positions reduced: 155
15% more first-time investments, than exits
New positions opened: 45 | Existing positions closed: 39
1% more funds holding
Funds holding: 459 → 464 (+5)
3% more capital invested
Capital invested by funds: $7.52B → $7.77B (+$256M)
0.47% less ownership
Funds ownership: 96.34% → 95.87% (-0.47%)
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
Top Buyers
Top Sellers
| 1 |
Envestnet Asset Management
Chicago,
Illinois
|
-$233M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$44.3M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$35.5M |
| 4 |
OAM
Ophir Asset Management
Sydney,
Australia
|
-$30.9M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$24.3M |
CHE Hedge Fund Activity: Q2 2023 in Review
464 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Chemed (CHE) for Q2 2023, worth a combined $7.77B — up 3.4% from $7.52B a quarter earlier.
Buyers outnumbered sellers: 45 funds opened new CHE positions and 39 closed out — a net gain of 6 holders — while 183 added to existing stakes and 155 trimmed.
The largest buyer was Durable Capital Partners, adding an estimated $104M. The largest seller was Envestnet Asset Management, cutting an estimated $233M.
- 464 institutional investors held Chemed (CHE) as of Q2 2023, up from 459 in Q1 2023.
- Funds reported $7.77B of Chemed stock for Q2 2023, up 3.4% quarter-over-quarter.
- 45 funds opened new Chemed positions in Q2 2023 and 39 closed out, a net change of +6 holders.
- The largest Chemed buyer in Q2 2023 was Durable Capital Partners, an estimated $104M added.
- The largest Chemed seller in Q2 2023 was Envestnet Asset Management, an estimated $233M sold.
Based on aggregated 13F filings for Q2 2023.